Zusammenfassung
Aborte sind Schwangerschaftsverluste vor der Lebensfähigkeit des Kindes. Die WHO- Definition von 1977 lautet: “the expulsion or extraction from its mother of an embryo or fetus weighing 500 g or less” [73]. Die Gewichtsdefinition entspricht etwa der 20.-22. SSW. Unterschieden werden Früh- von Spataborten. Die Grenze zwischen Friih- und Spätaborten liegt im Bereich der 16. SSW. Diese Differenzierung ist hinsichtlich der Abortursachen und eventueller prophylaktischer Maßnahmen von Bedeutung. Innerhalb der Gruppe der Friihaborte werden in neuerer Zeit noch Frühestaborte (nur biochemisch nachweisbar) von klinischen Aborten unterschieden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Acien P (1993) Reproductive performance of women with uterine malformations. Hum Reprod 8: 122–126
Alberman E (1988) The epidemiology of repeated abortion. In: Beard RW, Sharp F (eds) Early pregnancy loss: mechanisms and treatment. RCOG, London, pp 9–17
Armstrong BG, McDonald AD, Sloan M (1992) Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health 82: 85–87
Beer AE, Quebbeman JF, Ayers JW, Haines RF (1981) Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141: 987–999
Belanger K, Leaderer B, Hellenbrand K, Holford TR, McSharry J, Power ME, Bracken MB (1998) Spontaneous abortion and exposure to electric blankets and heated water beds. Epidemiology 9: 36–42
Breckwoldt M, Runnebaum B, Müller OA (1993) Weibliche Gonaden (Gynakologie und Geburtshilfe). In: Ziegler R, Pickardt CR, Willig R-P (Hrsg) Rationelle Diagnostik in der Endokrino-logie einschlie Blich Diabetologie und Stoffwechsel. Thieme, Stuttgart, S 213–221
Bussen S, Sutterlin M, Steck T (1999) Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 14: 18–20
Buttram VC Jr, Gibbons WE (1979) Mullerian anomalies: a proposed classification. (An analysis of 144 cases). Fertil Steril 32: 40–46
Buttram VC Jr, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36: 433–445
Capella-Allouc S, Morsad F, Rongieres-Bertrand C, Taylor S, Fernandez H (1999) Hysteroscopic treatment of severe Asherman’s syndrome and subsequent fertility. Hum Reprod 14: 1230–1233
Christiansen OB (1997) Epidemiological, immunogenetic and immunotherapeutic aspects of unexplained recurrent miscarriage. Dan Med Bull 44: 396–424
Clifford K, Rai R, Regan L (1997) Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 12: 387–389
Clifford K, Rai R, Watson H, Franks S, Regan L (1996) Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 312: 1508–1511
Clifford K, Rai R, Watson H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 9: 1328–1332
Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166: 1318–1323
Csapo Al, Pulkkinen M (1978) Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 33: 69–68
Daya S (1989) Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynaecol 96: 275–280
Deichert U, van de Sandt M, Lauth G, Daume E (1988) Dietransvaginale Hysterokontrast-sonographie (HKSG). Ein neuesVerfahren zur Differenzierung intrauteriner und myometraler Befunde. Geburtshilfe Frauenheilkd 48: 835–844
Doyle P, Maconochie N, Roman E, Davies G, Smith PG, Beral V (2000) Fetal death and congenital malformation in babies born to nuclear industry employees: report from the nuclear industry family study. Lancet 356: 1293–1299
Fenster L, Hubbard AE, Swan SH, Windham GC, Waller K, Hiatt RA, Benowitz N (1997) Caffeinated beverages, decaffeinated coffee, and spontaneous abortion. Epidemiology 8: 515–523
Filicori M, Butler JR, Crowley WF (1984): Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Gin Invest 73: 1638–1647
Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC (1989) A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 96: 265–274
Greaves M, Cohen H, MacHin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109: 704–715
Harlap S, Shiono PH (1980) Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 26: 173–176
Heidam LZ (1984) Spontaneous abortions among laboratory workers; a follow up study. J Epidemiol Community Health 38: 36–41
Hinney B, Henze C, Kuhn W, Wuttke W (1996) The corpus luteum insufficiency: a multifactorial disease. J Clin Endocrinol Metab 81: 565–570
Hinney B, Neumeyer H (1999) Immuntherapie habitueller Aborte. Reproduktionsmedizin 15: 200–211
Homer HA, Li TC, Cooke ID (2000) The septate uterus: a review of management and reproductive outcome. Fertil Steril 73: 1–14
The German RSA/IVIG Group (1994) Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J ObstetGynaecol 101: 1072–1077
Jivraj S, Anstie B, Cheong YC, Fairlie FM, Laird SM, Li TC (2001) Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study. Hum Reprod 16: 102–106
Jones GS (1949) Some newer aspects of the management of infertility. JAMA 141: 1123–1129
Kirk EP, Chuong CJ, Coulam CB, Williams TJ (1993) Pregnancy after metroplasty for uterine anomalies. Fertil Steril 59: 1164–1168
Koike T, Minakami H, Kosuge S, Usui R, Matsubara S, Izumi A, Sato I (1999) Uterine leiomyoma in pregnancy: its influence on obstetric performance. J Obstet Gynaecol Res 25: 309–313
Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174: 1584–1589
Lammer EJ, Chen DT, Hoar RM et al. (1985) Retinoic acid embryopathy. N Engl J Med 313: 837–841
Laskin CA, Bombardier C, Hannah ME et al. (1997) Prednisone and aspirin in women with autoantibodiesand unexplained recurrent fetal loss. N Engl J Med 337: 148–153
Li TC (1998) Recurrent miscarriage: principles of management. Hum Reprod 13: 478–482
Lutjen PJrounson A, Leeton J, Findlay J, Wood C, Renou P (1984) The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 307: 174–171
Macdonald RR(1989) Does treatment with progesterone prevent miscarriage? Br J Obstet Gynaecol 96: 257–260
Malik E, Berg C, Sterzik K, Stoz F, Rossmanith WG (2000) Reproductive outcome of 32 patients with primary or secondary infertility and uterine pathology. Arch Gynecol Obstet 264: 24–26
Medawar PB (1953) Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Experim Biol 7: 320–338
Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW (1985) Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet i: 941–943
Mueller-Eckhardt G, Heine O, Neppert J, Kunzel W, Mueller-Eckhardt C (1989) Prevention of recurrent spontaneous abortion by intravenous immunoglobulin. Vox Sang 56: 151–154
Nakajima ST, Nason FG, Badger GJ, Gibson M (1991) Progesterone production in early pregnancy. Fertil Steril 55: 516–521
Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Maternal age and fetal loss: population based register linkage study. BMJ 320: 1708–1712
Ogasawara M, Aoki K, Okada S, Suzumori K (2000) Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 73: 300–304
Ogasawara M, Kajiura S, Katano K, Aoyama T, Aoki K (1997) Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertil Steril 68: 806–809
Patton PE (1994) Anatomic uterine defects. Gin Obstet Gynecol 37: 705–721
Pauer HU, Hinney B, Voigt-Tschirschwitz T, Neesen J, Engel W (2001) Die Bedeutung von Faktor V G1691A-,FaktorllG20210A-und der Methylentetrahydrofolat-Reduktase-Mutationin der Diagnostik habitueller Aborte. Reproduktionsmedizin 17: 42–47
Prentice RL, Gatenby PA, Loblay RH, Shearman RP, Kronenberg H, Basten A (1984) Lupus anticoagulant in pregnancy. Lancet ii: 464
Rabinerson D, Johar M, Pomerantz M, Haimovich L (1992) Persistence of a normal pregnancy after an early luteectomy. A report of two cases. J Reprod Med 37: 749–752
Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ 314: 253–257
Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC (1997) Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med 337: 154–160
Regan L, Owen EJ, Jacobs HS (1990) Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336: 1141–1144
Rock JA, Schlaff WD (1985) The obstetric consequences of uterovaginal anomalies. Fertil Steril 43: 681–692
Scott JR, Rote NS, Branch DW (1987) Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 70: 645–656
Scott JR (2000) Immunotherapy for recurrent miscarriage (cochrane review). Cochrane Library, Oxford
Simon C, Martinez L, Pardo F, Jortajada M, Pellicer A (1991) Mullerian defects in women with normal reproductive outcome. Fertil Steril 56: 1192–1193
Speroff L, Glass RH, Kase NG (1999) Clinical gynecologic endocrinology and infertility. Lippincott Williams&Wilkins, Baltimore, pp 1043–1055
Stephenson MD (1996) Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 66: 24–29
Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB (1996) Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 65: 250–253
Stray-Pedersen B, Stray-Pedersen S (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148: 140–146
Stirrat GM (1990) Recurrent miscarriage I: Definition and epidemiology. Lancet 336: 673–675
Soliman S, Daya S, Collins J, Hughes EG (1994) The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 61: 1068–1076
Sutherland HW, Pritchard CW (1987) Increased incidence of spontaneous abortion in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 156: 135–138
Taskinen H, Lindbohm ML, Hemminki K (1986) Spontaneous abortions among women working in the pharmaceutical industry. Br J Ind Med 43: 199–205
Taylor C, Faulk WP (1981) Prevention of recurrent abortion with leucocyte transfusions. Lancet ii: 68–70
The American Fertility Society (1988) The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril 49: 944–955
Thornton CA, Ballow M (1993) Safety of intravenous immunoglobulin. Arch Neurol 50: 135–136
Tulppala M, Marttunen M, Soderstrom-Anttila V et al. (1997) Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 12: 1567–1572
Tulppala M, Stenman UH, Cacciatore B, Ylikorkala O (1993) Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol 100: 348–352
Tulppala M, Viinikka L, Ylikorkala O (1991) Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 337: 879–881
WHO (1977) WHO recommended definitions, terminology and format for statistical tables related to the perinatal period. Act Obstet Gynecol Scand 56: 247–253
Windham GC, Swan SH (1997) Moderate maternal drinking and infant birthweight. Epidemiology 8: 112–123
Recurrent Miscarriage Immunotherapy Trialists Group (1994) Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 32: 55–72
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hinney, B. (2002). Habituelle Abortneigung. In: Beck, L., Berg, D., Pfleiderer, A., Strowitzki, T. (eds) Gynäkologie upgrade 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56142-9_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-56142-9_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43398-9
Online ISBN: 978-3-642-56142-9
eBook Packages: Springer Book Archive